Compare HCM & HURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HCM | HURN |
|---|---|---|
| Founded | 2000 | 2002 |
| Country | Hong Kong | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.8B |
| IPO Year | N/A | 2004 |
| Metric | HCM | HURN |
|---|---|---|
| Price | $14.38 | $164.62 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $13.75 | ★ $215.50 |
| AVG Volume (30 Days) | 52.8K | ★ 161.0K |
| Earning Date | 03-18-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.32 |
| EPS | 0.53 | ★ 5.98 |
| Revenue | $602,197,000.00 | ★ $1,618,977,000.00 |
| Revenue This Year | N/A | $14.19 |
| Revenue Next Year | $15.54 | $9.49 |
| P/E Ratio | ★ $5.43 | $28.82 |
| Revenue Growth | N/A | ★ 12.67 |
| 52 Week Low | $11.51 | $120.25 |
| 52 Week High | $19.50 | $186.78 |
| Indicator | HCM | HURN |
|---|---|---|
| Relative Strength Index (RSI) | 43.28 | 36.53 |
| Support Level | $14.16 | $165.03 |
| Resistance Level | $15.82 | $173.04 |
| Average True Range (ATR) | 0.39 | 5.55 |
| MACD | -0.13 | -1.53 |
| Stochastic Oscillator | 10.14 | 21.96 |
HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.
Huron Consulting Group Inc is a professional services firm. The company provides expertise in technology, operations, advisory services, & analytics through three operating segments namely Healthcare, Education, and Commercial. Healthcare segment helps the firms to transform and innovate the delivery model to focus on patient wellness by improving quality outcomes, minimizing care variation and fundamentally improving patient and population health, Education segment provides management consulting and technology solutions, and Commercial segment is focused on serving industries and organizations facing disruption and regulatory change. It generates a majority of its revenue from the Healthcare Segment.